Drug Name: Qalsody
Indications: To treat amyotrophic lateral sclerosis in adults who have a SOD1 gene mutation.
Active Ingredient: Tofersen
Company: Biogen MA Inc.
Approval Date: 4/25/2023
More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215887s000lbl.pdf